Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rang in aandelen #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Aandeelprijs
$0.117
Laatst gesynchroniseerd: 2025-04-04
Marktkapitalisatie
$2.45M
Verandering (1 dag)
-13.59%
Verandering (1 jaar)
0.00%
Land
US
Handel Carmell Therapeutics Corporation (CTCX)

Categorie

Dividendrendementgeschiedenis voor Carmell Therapeutics Corporation (CTCX)
Het dividendrendement (TTM) van Carmell Therapeutics Corporation (aandelsymbool: CTCX) per 2023-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Carmell Therapeutics Corporation (CTCX) van 2021 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten